Usefulness of bone metabolic markers in the bone metastasis from lung cancer

G. Aygencel, C. Ozturk, H. Pasaoglu (Ankara, Turkey)

Source: Annual Congress 2002 - Lung cancer: clinical characteristics and prognosis
Session: Lung cancer: clinical characteristics and prognosis
Session type: Thematic Poster Session
Number: 1721

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Aygencel, C. Ozturk, H. Pasaoglu (Ankara, Turkey). Usefulness of bone metabolic markers in the bone metastasis from lung cancer. Eur Respir J 2002; 20: Suppl. 38, 1721

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bone metabolic markers in detecting bone metastasis of lung cancer
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010

Detection of bone metastases in patients with lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 65s
Year: 2001

The role of bisphosphonates in lung cancer patients with bone metastases
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007


Bone metastases of bronchial cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 77s
Year: 2002

Survival of lung cancer patients with bone metastases
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011

Bone marrow metastases in non-small cell lung cancer patients – a role of flow cytometry
Source: Eur Respir J 2006; 28: Suppl. 50, 782s
Year: 2006

Comparision of FDG PET/CT and bone scanning for bone metastases in operable non-small cell lung cancer
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

Relation between bone metastasis in lung cancer and serum IL-6 levels
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008

Detection of bone metastases in patients with NSCLC
Source: Eur Respir J 2002; 20: Suppl. 38, 185s
Year: 2002

Bone and Tl-201 image overlay in detection of musculoskeletal metastases of lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 245s
Year: 2003

Prognostic significance of cytokeratin positive cells in bone marrow of non-small cell lung cancer patients
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008


Is bone marrow biopsy needed in staging small cell carcinoma?
Source: Eur Respir J 2006; 28: Suppl. 50, 83s
Year: 2006

Markers of angiogenesis in serum are correlating with disease progress in lung cancer
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Evaluation of serum tumour markers in the lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 268s
Year: 2002

Increased serum levels of IL-18 are associated with lower survival and bone metastasis in non-small-cell lung cancer
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008

Contribution of tumor markers to pretreatment staging of operable lung cancer
Source: Eur Respir J 2003; 22: Suppl. 45, 360s
Year: 2003

Monitoring of lung function and airways inflammation after bone marrow transplantation
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008


Bone mineral density is associated with the risk of non-small cell lung cancer, the HUNT study
Source: Annual Congress 2012 - Environmental exposure and other risk factors for airway diseases
Year: 2012


Splenic metastasis of lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 91s
Year: 2006